» Articles » PMID: 18082604

A UAF1-containing Multisubunit Protein Complex Regulates the Fanconi Anemia Pathway

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2007 Dec 18
PMID 18082604
Citations 210
Authors
Affiliations
Soon will be listed here.
Abstract

The deubiquitinating enzyme USP1 controls the cellular levels of the DNA damage response protein Ub-FANCD2, a key protein of the Fanconi anemia DNA repair pathway. Here we report the purification of a USP1 multisubunit protein complex from HeLa cells containing stoichiometric amounts of a WD40 repeat-containing protein, USP1 associated factor 1 (UAF1). In vitro reconstitution of USP1 deubiquitinating enzyme activity, using either ubiquitin-7-amido-4-methylcoumarin (Ub-AMC) or purified monoubiquitinated FANCD2 protein as substrates, demonstrates that UAF1 functions as an activator of USP1. UAF1 binding increases the catalytic turnover (kcat) but does not increase the affinity of the USP1 enzyme for the substrate (KM). Moreover, we show that DNA damage results in an immediate shutoff of transcription of the USP1 gene, leading to a rapid decline in the USP1/UAF1 protein complex. Taken together, our results describe a mechanism of regulation of the deubiquitinating enzyme, USP1, and of DNA repair.

Citing Articles

Deubiquitinases and Cancer.

Murali P, Kavitha B, Narasimhan M J Pharm Bioallied Sci. 2025; 16(Suppl 5):S4210-S4220.

PMID: 40061651 PMC: 11888656. DOI: 10.4103/jpbs.jpbs_517_24.


The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy.

Hu X, Wu Y, Yao M, Chen Z, Li Q Future Med Chem. 2025; 17(3):329-345.

PMID: 39819213 PMC: 11792837. DOI: 10.1080/17568919.2025.2453414.


The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Tumors.

Cadzow L, Brenneman J, Tobin E, Sullivan P, Nayak S, Ali J Cancer Res. 2024; 84(20):3419-3434.

PMID: 39402989 PMC: 11474170. DOI: 10.1158/0008-5472.CAN-24-0293.


Structural and Biochemical Insights into the Mechanism of Action of the Clinical USP1 Inhibitor, KSQ-4279.

Rennie M, Gundogdu M, Arkinson C, Liness S, Frame S, Walden H J Med Chem. 2024; 67(17):15557-15568.

PMID: 39190802 PMC: 11403619. DOI: 10.1021/acs.jmedchem.4c01184.


ATAD5 functions as a regulatory platform for Ub-PCNA deubiquitination.

Ryu E, Yoo J, Kang M, Ha N, Jang Y, Kim J Proc Natl Acad Sci U S A. 2024; 121(34):e2315759121.

PMID: 39145935 PMC: 11348035. DOI: 10.1073/pnas.2315759121.